THE CORPORATE LIBRARY

Related Party Transactions and Outside Related Director Information

Vital Signs, Inc. (VITL)

4/3/2006 Proxy Information

No related party transactions or special transactions reported for this company. Director relationships marked "Outside Related" at this firm will most often be former executives of the company. Additional information regarding these relationships will be added during our regular updates.

5/12/2005 Proxy Information

Mr. Bershad (a director of the Company), through an investment limited partnership, Mr. Thomas (a former director and former executive of the Company) and Mr. MacCallum (a director of the Company) own 4.3%, 2.1% and less than 1% of X-Site, respectively. In May, 2004, substantially all of the assets of X-Site were sold to an unrelated third party. Thomas Medical Products, Inc. ('TMP'), a subsidiary of the Company, provides product development and manufacturing services to X-Site Medical, LLC ('X-Site'), a company engaged in the development of specialized cardiovascular products.

Thomas Medical Products, Inc. ('TMP'), a subsidiary of the Company, provides product development and manufacturing services to X-Site Medical, LLC ('X-Site'), a company engaged in the development of specialized cardiovascular products. Thomas Medical Products' sales to X-Site were approximately $67,000 during the fiscal year ended September 30, 2004, for these services. Amounts due from X-Site are included in accounts receivable on the Company's consolidated balance sheet and amounted to approximately $0 at September 30, 2004. The Company believes that the rates charged to X-Site for such services are no less favorable to the company than those charged to similarly situated unrelated parties. Mr. Wall (President, Chief Executive Officer and a director of the Company) and his family limited partnership own 37.6% of X-Site. Mr. Bershad (a director of the Company), through an investment limited partnership, Mr. Thomas (a former director and former executive of the Company) and Mr. MacCallum (a director of the Company) own 4.3%, 2.1% and less than 1% of X-Site, respectively. In May, 2004, substantially all of the assets of X-Site were sold to an unrelated third party.

4/9/2004 Proxy Information

Thomas Medical Products, Inc. ('TMP'), a subsidiary of the Company, provides product development and manufacturing services to X-Site Medical, LLC ('X-Site'), a company engaged in the development of specialized cardiovascular products. Thomas Medical Products' sales to X-Site were approximately $363,000 during the fiscal year ended September 30, 2003, for these services. Amounts due from X-Site are included in accounts receivable on the Company's consolidated balance sheet and amounted to approximately $199,000 at September 30, 2003. The Company believes that the rates charged to X-Site for such services are no less favorable to the Company than those charged to similarly situated unrelated parties. Mr. Wall (President, Chief Executive Officer and a director of the Company) and his family limited partnership own 37.6% of X-Site. Mr. Dimun (a 5% or greater beneficial owner of the Company's Common Stock), Mr. Bershad (a director of the Company), through an investment limited partnership, Mr. Thomas (a director of the Company) and Mr. MacCallum (a director of the Company) wn 3.9%, 4.3%, 2.1% and less than 1% of X-Site, respectively.

9/2/2003 Proxy Information

TMP, a subsidiary of the Company, loaned Mr. Thomas, a director of the Company, the sum of $637,350 and loaned his wife $233,370 on November 30, 2001, pursuant to unsecured promissory notes bearing interest at 5.5% per annum. Principal and interest under the notes are due and payable on November 30, 2004. The principal amount of these notes, together with interest accrued thereon, as of June 30, 2003 was $657,806 (with respect to Mr. Thomas' note) and $240,860 (with respect to his wife's note). All of such indebtedness (plus additional accrued interest) remained outstanding as of the date of this proxy statement. The largest aggregate amount of such indebtedness outstanding at any time during the period from October 1, 2001 through June 30, 2003 was $672,404 (with respect to Mr. Thomas' note) and $246,199 (with respect to his wife's note).

TMP provides product development and manufacturing services to X-Site Medical, LLC ('X-Site'), a company engaged in the development of specialized cardiovascular products. X-Site paid TMP $287,000 during fiscal 2002 for such services. As of June 30, 2003, a balance of $190,100 was outstanding for such services. The Company believes that the rates charged to X-Site for such services are no less favorable to the Company than those charged to similarly situated unrelated parties. Mr. Wall and his family limited partnership own 37.6% of X-Site. Mr. Dimun, Mr. Bershad, through an investment limited partnership, Mr. Thomas and Mr. MacCallum own 3.9%, 4.3%, 2.1% and less than 1% of X-Site, respectively.

During fiscal 2002, the Company paid Anthony J. Dimun, a director of the Company, $21,281 in consulting fees.